San Jose, CA, September 10, 2020: OptraHEALTH®, a leading data-driven intelligence company today announced that the United States Patent and Trademark Office(USPTO) has granted the patent to OptraHEALTH for healthcare AI applications with machine assisted process for health information handling.
San Jose, CA, August 19, 2020: OptraHEALTH®, a leading data-driven intelligence company, announced the collaboration with Johns Hopkins University for its flagship product GeneFAX™ for developing digital tools for patients. GeneFAX™ is an AI-powered, HIPAA-compliant knowledge platform for genetic health with BOT interfaces. This new-gen AI platform is suitable for educating patients, gathering their interest in various genetic tests, patient consenting, triaging, and pre-test and post-test counseling.
(RTTNews) - Molecular diagnostics company Myriad Genetics, Inc. (MYGN) announced Monday a new collaboration with AI platform OptraHEALTH to implement a cognitive ChatBOT named Gene to provide pre-test genetic and financial assistance information to prospective patients.
San Jose, Calif, January 21st, 2020: OptraHEALTH®,today announced that GeneFAX™, a conversational Genetic ChatBOT platform powered by Microsoft Azure AI, is now available as GeneFAX™ Pro on Microsoft Azure Marketplace ,online store providing applications and services for use on Azure.
San Jose, CA, and St. Petersburg, FL, November 5th, 2019: OptraHEALTH® and InformedDNA® today announced that they will partner to offer access to InformedDNA’s board-certified genetic counselors through GeneFAX’s AI-enabled CounselorConnect platform.
Patients to understand more about their genetic health through HIPPA Compliant GeneFAX™ ChatBOT on just a click
WASHINGTON (GenomeWeb) – This week, Optra Health, maker of the iPhronesis artificial intelligence platform for automated review of genetics literature and data, stepped into the consumer realm by introducing OptraGuru, an AI-based clinical report interpretation and guidance system.
SAN JOSE, Calif., Feb 20, 2018 (BUSINESS WIRE): OptraHEALTH®, today announced the introduction of a revolutionary new business solution—OptraGURU™. OptraGuru harnesses vast stores of genetic data
OptraHEALTH® today announced the introduction of a revolutionary new business solution—OptraGURU™. OptraGuru harnesses vast stores of genetic data locked away in corporate and public data silos, combines it with leading edge artificial intelligence and conversational technologies like Amazon Alexa to give genetic testing organizations the ability to offer a ‘round-the-clock’
Phoenix, USA
Gauri Naik
Optra Systems Inc., USA
Gauri Naik
Optra Systems Inc., USA
A company called OptraHEALTH®, announced what it calls a revolutionary new business solution — OptraGURU — which harnesses genetic data from corporate and public data silos, and combines it with AI and conversational technologies like Amazon Alexa, to give genetic testing organizations the ability to offer a personalized and engaging service to their consumers. Also, the service is made to help genetic counselors and scientists, as well.
San Jose, CA: A few weeks back, the digital healthcare company Optra Health announced the launch of OptraGURU, its newest platform that leverages the AI tech of its iPhronesis offering with Amazon Alexa’s natural language skills. What does that nearly run-on sentence really mean? This news marks a mash-up of 3 of our 2018 Trends and points to a revolution in the way everyday people understand and engage with their genetic information.
Myriad Genetics, Inc. MYGN recently announced a collaboration with OptraHEALTH with the aim of implementing a cognitive ChatBOT, Gene. The AI-powered ChatBOT will provide genetic and financial assistance information to prospective patients of hereditary cancer.
SALT LAKE CITY, July 06, 2020 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, today announced a new collaboration with OptraHEALTH® to implement a cognitive ChatBOT named Gene™ to provide genetic and financial assistance information to prospective patients.
SALT LAKE CITY, July 06, 2020 -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, today announced a new collaboration with OptraHEALTH® to implement a cognitive ChatBOT named Gene™ to provide genetic and financial assistance information to prospective patients.
Genetic diseases that run-in families predicate that other family members may require genetic testing -- GeneFAX™ CascadeBOT enables just that. GeneFAX™ InsuranceBOT addresses all aspects of health insurance and genetic testing. GeneFAX™ now also available on other social media apps
OptraHEALTH®,today announced that GeneFAX™, a conversational Genetic ChatBOT platform powered by Microsoft Azure AI, is now available as GeneFAX™ Pro on Microsoft Azure Marketplace ,online store providing applications and services for use on Azure.
Press Release
San Jose, CA, January 21st, 2020: OptraHEALTH®,today announced that GeneFAX™, a conversational Genetic ChatBOT platform powered by Microsoft Azure AI, is now available as GeneFAX™ Pro on Microsoft Azure Marketplace ,online store providing applications and services for use on Azure. The availability of GeneFAX™ Pro on Azure Marketplace will benefit genetic testing providers for their DTC as well as Diagnostics tests.
Press Release
Come find out what’s shaping the future of genetic health.
Join us at the 2020 ACMG Annual Clinical Genetics Meeting (Booth #610) where we will be showcasing GeneFAX™: Conversational AI Platform for Genetic Health. GeneFAX™ enhances genetic testing processes using AI based workflows and is complete with ScreeningBOT, KnowledgeBOT, QuizBOT, PhysicianBOT, PedigreeBOT and much more.
Nov 06, 2019 | staff reporter
NEW YORK – OptraHealth said today that it is partnering with InformedDNA to make the latter's network of genetic counselors remotely available to users of the OptraHealth GeneFax automated clinical report interpretation and guidance system.
Patients gain additional access to expert genetic counseling from anywhere in the U.S. through the GeneFAX™ AI Platform
Press Release
Patients gain additional access to expert genetic counseling from anywhere in the U.S. through the GeneFAX™ AI Platform
Press Release
Join us for the 2019 ACMG Annual Clinical Genetics Meeting (Booth #1016) where we will be showcasing our Coversational AI for Genetics platform 'GeneFAXTM : Digital Genetic Health Companion'.
Press Release
OptraHEALTH, the leading data-driven intelligence company, today announced that Dr. Gauri Naik, Founder & CEO, has received the prestigious ‘Women Entrepreneur 2019’ Award from DMA in association with Government of India.
Press Release
OptraHEALTH launches world first digital genetic companion on Android. Powered by the most advanced conversational AI technologies, GeneFAX™ allows users to get answers about genetics and genetic testing in a very simple, succinct and easy to understand manner.
Press Release
Powered by the most advanced Artificial Intelligence and Conversational technologies available, GeneFAX™ changes the way consumers, genetic counselors, and scientists will interact with complex genetic data and how they will engage with genetic testing providers.
Press Release
OptraHEALTH®, which produces AI-driven iPhronesis analysis platform for healthcare and life sciences clients, today announced the launch of a new genetics-focused product specially designed for consumers, genetic counselors, and other genomics researchers.
iPhronesis Knowledge Automation Platform Uses Cognitive Crawling, Deep Machine Learning and Advanced Natural Language Processing to Help Automate Data Curation, Variant Classification and Clinical Reporting; Visit Optra Health at ACMG Clinical Genetics Annual Meeting
